Jerry Snidow

541 total citations
18 papers, 432 citations indexed

About

Jerry Snidow is a scholar working on Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jerry Snidow has authored 18 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jerry Snidow's work include Gastrointestinal motility and disorders (4 papers), Neonatal Respiratory Health Research (4 papers) and Preterm Birth and Chorioamnionitis (4 papers). Jerry Snidow is often cited by papers focused on Gastrointestinal motility and disorders (4 papers), Neonatal Respiratory Health Research (4 papers) and Preterm Birth and Chorioamnionitis (4 papers). Jerry Snidow collaborates with scholars based in United States, United Kingdom and Netherlands. Jerry Snidow's co-authors include Amy Pierce, Eric Mortensen, C. Kleoudis, Ben Lasko, Gordon Irving, John I. Wurzelmann, Eric Carter, Bart Morlion, Lynn R. Webster and John F. Peppin and has published in prestigious journals such as Pain, American Journal of Obstetrics and Gynecology and British Journal of Clinical Pharmacology.

In The Last Decade

Jerry Snidow

17 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry Snidow United States 10 175 166 79 77 59 18 432
Sun Hwan Bae South Korea 12 128 0.7× 75 0.5× 65 0.8× 52 0.7× 28 0.5× 49 454
Ann R. McMeans United States 9 68 0.4× 367 2.2× 89 1.1× 39 0.5× 45 0.8× 15 611
Abhijeet Singh India 10 128 0.7× 73 0.4× 223 2.8× 13 0.2× 4 0.1× 26 428
K. L. Merkel United States 9 51 0.3× 34 0.2× 40 0.5× 122 1.6× 6 0.1× 22 510
Malcolm Miller South Africa 9 155 0.9× 17 0.1× 38 0.5× 18 0.2× 3 0.1× 23 326
Paolo Siani Italy 10 57 0.3× 33 0.2× 29 0.4× 60 0.8× 4 0.1× 36 378
Michael Stenger United States 14 258 1.5× 102 0.6× 15 0.2× 97 1.3× 38 567
Dinesh Ganapathy United States 8 83 0.5× 24 0.1× 45 0.6× 9 0.1× 3 0.1× 9 387
Emmanuel Anteyi Nigeria 8 28 0.2× 39 0.2× 58 0.7× 7 0.1× 10 0.2× 11 391
Tracy Sandritter United States 11 75 0.4× 12 0.1× 27 0.3× 100 1.3× 2 0.0× 27 312

Countries citing papers authored by Jerry Snidow

Since Specialization
Citations

This map shows the geographic impact of Jerry Snidow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Snidow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Snidow more than expected).

Fields of papers citing papers by Jerry Snidow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Snidow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Snidow. The network helps show where Jerry Snidow may publish in the future.

Co-authorship network of co-authors of Jerry Snidow

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Snidow. A scholar is included among the top collaborators of Jerry Snidow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Snidow. Jerry Snidow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Powell, Marcy, Jeanne M. Pimenta, Kathleen J. Beach, et al.. (2021). Safety and Outcomes in Infants Born to Mothers Participating in Retosiban Treatment Trials: ARIOS Follow-up Study. American Journal of Perinatology. 40(10). 1135–1148.
2.
Saade, George R., Andrew Shennan, Kathleen J. Beach, et al.. (2020). Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor. American Journal of Perinatology. 38(S 01). e309–e317. 8 indexed citations
3.
Thornton, Steven, Guillermo J. Valenzuela, Charlotte A. Baidoo, et al.. (2017). Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose‐ranging study. British Journal of Clinical Pharmacology. 83(10). 2283–2291. 9 indexed citations
4.
Thornton, Steven, Hugh Miller, Guillermo J. Valenzuela, et al.. (2015). Treatment of spontaneous preterm labour with retosiban: a phase 2 proof‐of‐concept study. British Journal of Clinical Pharmacology. 80(4). 740–749. 16 indexed citations
5.
Snidow, Jerry, Hugh Miller, Steve Thornton, et al.. (2012). 350: A multicenter, randomized, double-blind, placebo-controlled phase 2 trial of retosiban, a selective oxytocin receptor antagonist, for the management of preterm labor. American Journal of Obstetrics and Gynecology. 208(1). S155–S155. 6 indexed citations
6.
Jansen, Jan‐Peter, Daniel Lorch, Ben Lasko, et al.. (2011). A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/012) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain. Journal of Pain. 12(2). 185–193. 59 indexed citations
7.
Irving, Gordon, Brian Ramjattan, Michael J. Cousins, et al.. (2011). A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain. Journal of Pain. 12(2). 175–184. 59 indexed citations
8.
Abernethy, Amy P., David C. Currow, John I. Wurzelmann, et al.. (2010). Enhancing enrollment in palliative care trials: key insights from a randomized, placebo-controlled study.. PubMed. 8(3). 139–44. 19 indexed citations
9.
10.
Sabatowski, R., Anne M. Rentz, C. Kleoudis, et al.. (2006). 696 EFFECT OF ALVIMOPAN ON HEALTH‐RELATED QUALITY OF LIFE (HRQOL) IN SUBJECTS WITH OPIOID‐INDUCED GASTROINTESTINAL (GI) SIDE EFFECTS: THE PAC‐QOL QUESTIONNAIRE. European Journal of Pain. 10(S1). 3 indexed citations
11.
Keiser, Philip, Michael Sension, Edwin DeJesus, et al.. (2005). Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment. BMC Infectious Diseases. 5(1). 2–2. 31 indexed citations
12.
Swindells, Susan, Calvin Cohen, Daniel S Berger, et al.. (2005). Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens. BMC Infectious Diseases. 5(1). 23–23. 6 indexed citations
13.
Hendrix, Craig W., Mary Beth Wire, Yu Lou, et al.. (2004). Pharmacokinetics and Pharmacodynamics of Methadone Enantiomers After Coadministration with Amprenavir in Opioid‐Dependent Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(9). 1110–1121. 26 indexed citations
14.
Al‐Harthi, Lena, John C. Voris, Simone Becker, et al.. (2004). Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients. HIV Medicine. 5(1). 55–65. 31 indexed citations
15.
Rainey, Petrie M., Gerald Friedland, Jerry Snidow, et al.. (2002). The Pharmacokinetics of Methadone Following Co‐Administration with a Lamivudine/Zidovudine Combination Tablet in Opiate‐Dependent Subjects. American Journal on Addictions. 11(1). 66–74. 26 indexed citations
16.
Snidow, Jerry, et al.. (1990). Loperamide Hydrochloride. American Pharmacy. 30(12). 45–48. 7 indexed citations
17.
Snidow, Jerry, et al.. (1987). Acute effects of short-term subcutaneous terbutaline on theophylline disposition. European Journal of Clinical Pharmacology. 32(2). 191–193. 6 indexed citations
18.
Burckart, Gilbert J., et al.. (1981). Neutropenia Following Acute Chlorpromazine Ingestion. Clinical toxicology. 18(7). 797–801. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sun Hwan Bae Breakdown of academic impact, for papers by Ann R. McMeans Breakdown of academic impact, for papers by Abhijeet Singh Breakdown of academic impact, for papers by K. L. Merkel Breakdown of academic impact, for papers by Malcolm Miller Breakdown of academic impact, for papers by Paolo Siani Breakdown of academic impact, for papers by Michael Stenger Breakdown of academic impact, for papers by Dinesh Ganapathy Breakdown of academic impact, for papers by Emmanuel Anteyi Breakdown of academic impact, for papers by Tracy Sandritter
Rankless by CCL
2026